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ABSORPTION OF CONTROLLED RELEASE MORPHINE
SULPHATE IN THE IMMEDIATE POSTOPERATIVE PERIOD
C. A. PINNOCK, D. R. DERBYSHIRE, K. J. ACHOLA AND G. SMITH
A controlled release formulation of morphine
sulphate (MST Continus, Napp Laboratories)
has been advocated as a postoperative analgesic
agent (Fell, Chmielewski and Smith, 1982;
Derbyshire et al., 1984) in those patients for whom
an opioid agent is deemed necessary. In a previous
study MST 20 mg, administered every 4 h, was
shown to provide acceptable analgesia after
hysterectomy or cholecystectomy (Derbyshire et
al., 1985). However, the unexpectedly low serum
morphine concentrations (mean 1.9 ng ml"1)
found 18 h after surgery led to concern that the
decrease in gastric motility, which occurs com-
monly after anaesthesia and surgery, might have
led to the accumulation of MST in the stomach.
Anaesthetic techniques which use opioids are
known to inhibit gastric emptying temporarily
(Nimmo, 1984). Later "dumping"of any accumu-
lated drug into the small intestine (from which it
is absorbed) would then present a potential hazard.
The present study was designed to examine the
absorption of MST immediately after a standard
general anaesthetic technique and to compare the
results with those obtained previously in healthy
non-anaesthetized volunteers.
PATIENTS AND METHODS
Ten patients (mean age 72 yr (range 54-86 yr);
mean weight 69 kg (range 59-84 kg)) undergoing
peripheral arterial surgery for which arterial
cannulation and intensive postoperative monitor-
ing were deemed necessary were studied. Patients
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SUMMARY
The absorption of morphine sulphate, given orally
as a controlled release preparation, was studied
in 10 patients who had undergone peripheral
vascular surgery with a standard opioid-based
general anaesthetic technique. Serum morphine
concentrations were measured (high pressure
liquid chromatography) every 2 h for the first
16 h after surgery and the results were strongly
suggestive of a decrease in the rate of absorption
of morphine in this situation.
with significant preoperative pain, or who were
receiving opioid therapy or who had a history of
gastrointestinal pathology were excluded from the
study.
All patients received a standard anaesthetic
technique . Following premedication with diaze-
pam 10 mg by mouth, sodium thiopentone 3 mg
kg"1 was administered. Anaesthesia was main-
tained with 66 % nitrous oxide in oxygen. Fentanyl
was administered as necessary for the suppression
of reflex responses, and controlled ventilation to
normocapnia was facilitated by the administration
of atracurium. The mean dose of fentanyl
administered was 365 ug (range 300-450 ng).
After surgery the patients were prescribed MST
20 mg 4-hourly by mouth for analgesia. They
were monitored (continuous ECG and direct
arterial pressure recording) in the recovery suite
for a period of 18-24 h.
Arterial blood was sampled every 2 h for 16 h.
Time "zero" (control) was denned (for each
patient) as the moment immediately before the
administration of the first dose of MST. MST was
administered once each patient could swallow
adequately (in all patients this occurred within
30 min of the end of the operative procedure).
Blood samples were allowed to clot and centrifuged
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TABLE I. Demographic details of the patients in the study
Age(yr)
59
70
64
73
76
86
54
80
79
74
Weight (kg)
60
59
84
80
64
60
68
74
70
69
Procedure
Femoro-popliteal graft
Femoro-popliteal graft
Femoro-popliteal graft
Axillo-bifemoral graft
Femoro-popliteal graft
Femoro-femoral graft
Femoro-popliteal graft
Femoro-popliteal graft
Femoro-femoral graft
Femoro-popliteal graft
at 5000 rev min 1 for 15 min. The supernatant
serum was extracted and frozen at — 70 °C pend-
ing analysis for serum morphine concentration.
Serum morphine concentrations were measured
by high pressure liquid chromatography (HPLC)
with electrochemical detection (Aitkenhead et al.,
1984). The lower limit of detection of this assay
is 1 ng ml"1, and the coefficient of variation is
less than 5%. The assay is specific to "free"
morphine and does not measure the glucuronides
of morphine, which are extracted into aqueous
solution before chromatography.
RESULTS
Demographic details of the patients and the
procedures undertaken are shown in table I.
Figure 1 represents a plot of mean serum
morphine concentrations against time for the first
16 h after surgery in nine patients. No morphine
was detected in the control samples. Thereafter,
serum morphine concentrations increased from a
mean of l^ngml" 1 at 2h to a mean of
12.4 ng ml"1 at 14 h. There is clearly a delay in the
increase in serum concentrations over this period
in comparison with the pattern seen from another
study in volunteers (who had not undergone
surgery and anaesthesia) who received MST
20 mg as a single dose (Vater et al., 1984).
Each patient was questioned hourly by the
recovery suite nursing staff as to whether or not he
was in pain. Although nine patients questioned
thus had adequate analgesia, tie respective serum
morphine concentrations were considerably lower
than the 50 ng ml"1 which has been suggested as
the value providing postoperative analgesia
(Berkovitz et al., 1975) in studies in which
morphine was measured by radioimmunoassay
techniques. However, in a study by Dahlstrom and
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FIG. 1. Serum morphine concentrations in patients given MST
20 mg every 4 h by mouth, commencing at time 0 (o O)
following peripheral vascular surgery (mean ± SEM, n = 9).
For comparison data from Vater and colleagues (1984) are also
plotted (o o)j showing the profile of serum morphine
concentrations in volunteers following a single dose of MST
20 mg (mean ± SEM, n = 11).
colleagues (1982) the minimum effective analgesic
concentration for morphine (plasma values
measured by HPLC) was 16 ng ml"1.
The single patient who complained of pain had
vomited after each dose of MST and the measured
serum morphine concentrations in this patient
were consistently less than 2 ng ml"1. Analgesia
was supplemented by fentanyl i.v. in this
individual and the serum morphine concentra-
tions have been omitted from the data shown in
figure 1.
Although the nursing staff received instructions
to omit a scheduled dose of MST if they
considered the patient to be excessively sedated,
this was not necessary in any patient throughout
the first 24 h of the postoperative period (when
strong analgesic drugs are usually required).
DISCUSSION
The pattern, displayed in figure 1, of a slow and
delayed increase in serum morphine concentrations
is strongly indicative of a delay in the absorption
of MST—especially in the period immediately
after operation.
In the study by Vater and colleagues (1984) in
which starved volunteers received a single dose of
20 mg MST, the mean peak plasma morphine
870
concentration was 14.8 ng ml"1 and occurred
within a mean 143 min of administration. The
serum morphine concentration-time data from
those volunteers have been plotted in figure 1
(dashed line) for comparison with the present data.
In a more recent study of 29 volunteers given
MST 30 mg the mean peak serum morphine
concentration was 11.6 ng ml"1 and occurred at a
mean time of 120 min following administration
(Pinnock, Derbyshire and Aitkenhead, unpub-
lished observations). In both these studies,
morphine concentrations were measured using the
same HPLC technique as in the present study
(Aitkenhead et al., 1984). Thus the pattern shown
for patients given MST 20 mg every 4 h contrasts
sharply with the early peak and decay seen
following a single dose of MST 20 mg in
volunteers who had not undergone anaesthesia and
surgery.
It is well documented that anaesthesia utilizing
opioid drugs may cause a temporary inhibition of
gastric emptying (Nimmo et al., 1975; Nimmo,
1976). In contrast, there is little effect on gastric
motility, following anaesthesia for minor pro-
cedures, when opioids are not used (Reilly and
Nimmo, 1984).
It seems reasonable to postulate, therefore, that
intestinal motility was decreased in the patients
examined in the present study following the i.v.
administration of fentanyl. In addition, it should
be emphasized that the majority of patients
undergoing major surgery will normally receive
opioids i.v. during the course of anaesthesia. Park
and Weir (1984) demonstrated in healthy volun-
teers that MST per se has little effect on gastric
emptying (whereas morphine i.m. may cause a
considerable reduction) as assessed by the
measurement of plasma paracetamol concentra-
tions. This may be accounted for by the difference
in plasma concentrations of morphine produced
by the two different routes of administration. In
the study of Park and Weir (1984) the oral MST
administered to healthy volunteers was associated
with a "normal" profile of plasma concentrations
of morphine and a mean peak of around 6 ng ml"1,
whereas the i.m. route of administration was
associated with a peak plasma concentration of
approximately 30 ng ml"1.
In the absence of physical obstruction to the
gastric outlet (such as pyloric stenosis) opioid
analgesic drugs are the major cause of delayed
gastric emptying in the preoperative period
(Nimmo, 1984). The results of the present study
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would appear to provide evidence supplementary
to that of Derbyshire and colleagues (1985)
suggesting that the rate of absorption of MST in
the early postoperative period is reduced following
anaesthesia comprising a nitrous oxide in oxygen—
neuromuscular blocker-opioid sequence.
A corollary of this statement is that, when
normal gastric activity resumes, passage of
accumulated MST into the small intestine may
lead to excessively high blood concentrations of
morphine, particularly if the period of gastric
stasis is prolonged and oral administration of the
drug is continued. Such a situation may be most
likely to occur in a patient who has undergone
intra-abdominal surgery following which the
incidence of paralytic ileus is high. Whilst many
factors are of importance in the aetiology of gastric
stasis following surgery, the risk of accumulation
of MST within the stomach followed by later
absorption may be seen to be of relevance,
independent of the precise mechanism underlying
the inhibition of gastric transport.
The absorption of a substantial amount of
morphine into the systemic circulation following
regular administration of MST to a patient with
gastric stasis is obviously hazardous. Estimates of
the systemic bioavailability of MST have been
quoted between 18% (Vater et al., 1984) and
100% (McQuay et al., 1983) and thus it is difficult
to predict for any one individual the dose of MST
which would lead to excessive blood concentrations
should gastric stasis and "dumping" occur.
Attention has already been drawn to the death of
a patient following the use of MST for post-
operative pain relief (Brahams, 1984). Thus,
extreme caution must be advocated in the use of
MST in the early postoperative period. However,
it should be noted that, in the present study, the
later postoperative course of these patients was
uneventful. No patient exhibited excessive drowsi-
ness as might have been expected if "dumping"
of accumulated MST was occurring.
Although consideration of the quality of
analgesia was beyond the scope of this study, it is
noteworthy that in the second 24-h period after
surgery only two patients required further anal-
gesia (this was a single dose of morphine sulphate
10 mg i.m.).
The intraoperative consumption of fentanyl in
all 10 patients was modest (mean 365 ug, range
300-450 ng). It is surprising, therefore, that
satisfactory analgesia was achieved at low serum
morphine concentrations and it is tempting to
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speculate that this may be related to the
biotransformation of morphine administered by
mouth. All patients had evidence of partial
absorption of MST as shown by detectable serum
morphine concentrations from 2 h onwards. One
significant breakdown pathway of morphine is by
hepatic conjugation. A major metabolite from this
pathway is morphine-3-glucuronide, which is not
known to possess any analgesic properties. A
smaller proportion of the administered dose is
conjugated to morphine-6-glucuronide (M6G).
M6G is thought to be three times as potent as an
analgesic as free morphine and it is possible that
an element of the analgesia seen in these patients
is related to M6G.
(NOTE : The revised data sheet for MST Continus
from Napp Laboratories does not recommend the
use of MST in the early postoperative period.)
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